Literature DB >> 21904778

Dosing of glucocorticosteroids in nephrotic syndrome.

Otto Mehls1, Peter F Hoyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21904778     DOI： 10.1007/s00467-011-1993-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  27 in total

Review 1.  Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder.

Authors:  Evangelia Charmandari; Tomoshige Kino; Takamasa Ichijo; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2008-03-04       Impact factor: 5.958

2.  Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis.

Authors:  Jun Oh; Julia Beckmann; Jacek Bloch; Verena Hettgen; Julian Mueller; Li Li; Meike Hoemme; Marie-Luise Gross; Roland Penzel; Peter Mundel; Franz Schaefer; Claus P Schmitt
Journal:  Kidney Int       Date:  2011-04-20       Impact factor: 10.612

Review 3.  Rapid non-genomic effects of corticosteroids and their role in the central stress response.

Authors:  Femke L Groeneweg; Henk Karst; E Ron de Kloet; Marian Joëls
Journal:  J Endocrinol       Date:  2011-02-28       Impact factor: 4.286

Review 4.  Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  Ellen T McCarthy; Mukut Sharma; Virginia J Savin
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-21       Impact factor: 8.237

5.  Methylprednisolone exposure, rather than dose, predicts adrenal suppression and growth inhibition in children with liver and renal transplants.

Authors:  S Sarna; K Hoppu; P J Neuvonen; J Laine; C Holmberg
Journal:  J Clin Endocrinol Metab       Date:  1997-01       Impact factor: 5.958

6.  Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology.

Authors:  P Niaudet
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

7.  Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.

Authors:  Peter F Hoyer; Johannes Brodeh
Journal:  J Am Soc Nephrol       Date:  2006-03-15       Impact factor: 10.121

8.  Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes.

Authors:  Etsuko Yanagida-Asanuma; Katsuhiko Asanuma; Kwanghee Kim; Mary Donnelly; Hoon Young Choi; Jae Hyung Chang; Shiro Suetsugu; Yasuhiko Tomino; Tadaomi Takenawa; Christian Faul; Peter Mundel
Journal:  Am J Pathol       Date:  2007-06-14       Impact factor: 4.307

9.  Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Authors: 
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321

10.  Mizoribine corrects defective nephrin biogenesis by restoring intracellular energy balance.

Authors:  Aya Nakajo; Jamshid Khoshnoodi; Hitoshi Takenaka; Emi Hagiwara; Takashi Watanabe; Hayato Kawakami; Ryota Kurayama; Yuji Sekine; Fumio Bessho; Shori Takahashi; Agnieszka Swiatecka-Urban; Karl Tryggvason; Kunimasa Yan
Journal:  J Am Soc Nephrol       Date:  2007-08-08       Impact factor: 10.121
View more
  9 in total

1.  Weight dosing of steroids in nephrotic syndrome.

Authors:  Thomas J Neuhaus; Guido F Laube
Journal:  Pediatr Nephrol       Date:  2011-12-31       Impact factor: 3.714

2.  Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.

Authors:  Vaishnavi Raman; Sriram Krishnamurthy; K T Harichandrakumar
Journal:  Pediatr Nephrol       Date:  2016-01-12       Impact factor: 3.714

3.  Two dosing regimens for steroid therapy in nephrotic syndrome.

Authors:  Daishi Hirano; Shuichiro Fujinaga
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

Review 4.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Narelle S Willis; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2015-03-18

5.  Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.

Authors:  Yael Borovitz; Hadas Alfandary; Orly Haskin; Shely Levi; Shulamit Kaz; Miriam Davidovits; Amit Dagan
Journal:  Eur J Pediatr       Date:  2019-11-14       Impact factor: 3.183

Review 6.  Update on the treatment of steroid-sensitive nephrotic syndrome.

Authors:  Federica Zotta; Marina Vivarelli; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2021-03-05       Impact factor: 3.714

Review 7.  The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapse.

Authors:  Andrea Pasini; Elisa Benetti; Giovanni Conti; Luciana Ghio; Marta Lepore; Laura Massella; Daniela Molino; Licia Peruzzi; Francesco Emma; Carmelo Fede; Antonella Trivelli; Silvio Maringhini; Marco Materassi; Giovanni Messina; Giovanni Montini; Luisa Murer; Carmine Pecoraro; Marco Pennesi
Journal:  Ital J Pediatr       Date:  2017-04-21       Impact factor: 2.638

8.  Treatment of idiopathic nephrotic syndrome with two steroid dosing regimens - one-year observational study.

Authors:  Małgorzata Pańczyk-Tomaszewska; Piotr Skrzypczyk; Kacper Mroczkowski; Beata Leszczyńska; Małgorzata Mizerska-Wasiak
Journal:  Cent Eur J Immunol       Date:  2021-10-06       Impact factor: 2.085

Review 9.  Optimizing the corticosteroid dose in steroid-sensitive nephrotic syndrome.

Authors:  Martin T Christian; Andrew P Maxted
Journal:  Pediatr Nephrol       Date:  2021-02-20       Impact factor: 3.651
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.